Zymeworks Inc. Common Stock (ZYME) — Cash Flow Reinvestment Rate
Zymeworks Inc. Common Stock (ZYME) has a Cash Flow Reinvestment Rate of 0.80x as of June 2025, reinvesting $9.63 Million (capex $884.00K plus investments $8.74 Million) from operating cash flow of $12.07 Million. See ZYME FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zymeworks Inc. Common Stock Cash Flow Reinvestment Rate (2017–2022)
Historical reinvestment intensity for Zymeworks Inc. Common Stock across 3 annual periods. For the full cash flow conversion analysis, see ZYME cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Zymeworks Inc. Common Stock (2017–2022)
Year-by-year capital reinvestment analysis for Zymeworks Inc. Common Stock. See financial flexibility index of Zymeworks Inc. Common Stock to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.46x | $66.97 Million | $144.11 Million | $13.12 Million | ▼ -89.7% |
| 2018 | 4.51x | $109.05 Million | $24.18 Million | $3.42 Million | ▼ -96.8% |
| 2017 | 141.04x | $30.89 Million | $219.00K | $3.12 Million | — |